Mefloquine during the study. Mefloquine was the first Public-Private Venture (PPV) between the US Department of Defense and a pharmaceutical company. WRAIR transferred all its phase I and phase II clinical trial data to Hoffman LaRoche and Smith Kline. FDA approval as a treatment for malaria was swift. Most notably, phase III safety and tolerability trials were skipped. The drug was first approved and sold on a commercial basis in Switzerland in 1985. However, mefloquine was not approved by the FDA for prophylactic use until 1989. This approval was based primarily on compliance, while safety and tolerability were overlooked. Because of
International Association for the Treatment of Sexual Offenders assessment and/or treatment of a child or juvenile who has committed a sexual offense: International Association for the Treatment of Sexual Offenders The International Association for the Treatment of Sexual Offenders (IATSO) is an international non-profit professional organization based in Vienna committed to the promotion of research of and treatment for sex offenders throughout the world. IATSO was founded in March 24, 1998 in Caracas, Venezuela during the 5th International Conference on the Treatment of Sex Offenders. They publish "Sex Offender Treatment", an international peer-reviewed journal open to all scientists and practitioners researching sexual abuse. In 2014 the first ever